Evidence map›Paper›PMID 41003560›Full record

ArticleTropical medicine and infectious disease2025

Interleukin-8 Predicts Fatal Kala-Azar: A Case-Control Study.

Simone Soares Lima, Débora Cavalcante Braz, Vladimir Costa Silva, Teresinha de Jesus Cardoso Farias Pereira, Líndia Kalliana da Costa Araújo Alves Carvalho, Dorcas Lamounier Costa, Carlos Henrique Nery Costa

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simone Soares LimaDepartment of Maternal and Child Health, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil.ORCID 0000-0002-3013-8778
Débora Cavalcante BrazPharmacy Course, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil.ORCID 0000-0001-5978-1241
Vladimir Costa SilvaLaboratory of Genomic Surveillance and Molecular Biology (LVGBM), Oswaldo Cruz Foundation (FIOCRUZ-PIAUI), Teresina 64000-128, Piauí, Brazil.ORCID 0000-0003-3109-7899
Teresinha de Jesus Cardoso Farias PereiraSecretary of Education of Piauí, Teresina 64081-110, Piauí, Brazil.ORCID 0000-0002-9213-4027
Líndia Kalliana da Costa Araújo Alves CarvalhoPostgraduate Program in Biotechnology, Northeast Network of Biotechnology (RENORBIO), Federal University of Piauí, Teresina 64049-550, Piauí, Brazil.ORCID 0000-0001-5545-6943
Dorcas Lamounier CostaDepartment of Maternal and Child Health, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil.ORCID 0000-0001-7115-7978
Carlos Henrique Nery CostaIntelligence Center for Emerging and Neglected Tropical Diseases (CIATEN), Teresina 64001-020, Piauí, Brazil.ORCID 0000-0001-7302-2006

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 404128/2013-0
6 · The paper itself

Abstract

Kala-azar is associated with case-fatality rates as high as 10% in certain regions. Early identification of mortality biomarkers can significantly reduce this risk. This study, strengthened by a relatively high number of kala-azar-related deaths, aimed to identify serum cytokines as predictive biomarkers of fatal kala-azar. We compared 48 deceased patients with kala-azar to 42 survivors. The concentrations of IL-1β, IL-6, IL-8, IL-10, IL-12, and tumor necrosis factor-α (TNF-α) were measured by flow cytometry. Cytokine levels were compared between groups using the Wilcoxon rank-sum test. Receiver operating characteristic (ROC) analysis, coupled with Youden's index, defined the optimal diagnostic threshold. Upon admission, IL-8 concentrations were substantially higher in deceased kala-azar patients (median 76.5 pg/mL [IQR 35.2-242.4 pg/mL]) than in survivors (median 26.4 pg/mL [IQR 15.1-47.7 pg/mL];

Indexed as

cytokinesinflammationmortalityprognosisvisceral leishmaniasis

Identifiers

PMID41003560
PMCPMC12474104

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.